We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

New Long-acting Contraceptive Designed to Be Self-administered

News   Jan 15, 2019 | Original story the Georgia Institute of Technology

 
New Long-acting Contraceptive Designed to Be Self-administered

Regents' Professor Mark Prausnitz holds an experimental microneedle contraceptive skin patch. Designed to be self-administered by women for long-acting contraception, the patch could provide a new family planning option. Credit: Christopher Moore, Georgia Tech

 
 
Advertisement
 

RELATED ARTICLES

FDA Approves a Novel Medicine Invented at Scripps Research, For Treatment of Multiple Sclerosis

News

Ozanimod is the latest in a series of novel medicines to originate from the laboratories of Scripps Research.

READ MORE

The National Gene Vector Biorepository

News

Gene therapy investigators can greatly benefit from the resources and services provided by the National Gene Vector Biorepository.

READ MORE

Aiding COVID-19 Data Analysis

News

Researchers from the Centre for Genomic Regulation (CRG) have launched a new database to advance the international research efforts studying COVID-19.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE